Cross functional product leadership across all 5 solid organ franchisees (heart, lung, liver, kidney, pancreas) to identify new growth opportunities as well as drive continuous growth in core portfolio. Direct reporting to C-Suite. Partnering closely with R&D, medical affairs, operations, manufacturing, sales, and clinical field support on various product, digital, and service offerings across organ transplant space. Managing multiple KOL relationships worldwide on various upstream and downstream initiatives.

Backed by rigorous clinical evidence, Paragonix is establishing a new standard of care for the Organ Transplant Journey. The company designs, develops, and manufacturers organ preservation systems, digital ecosystem for care coordination, and runs the world's largest real world registry studying the impact of organ preservation on post transplant outcomes. Full upstream and downstream responsibility, including strategic account engagement, strategy, commercial presentations, and sales support. Global expansion of portfolio by partnering with key thought leaders and hospital networks Identifying and advancing new innovation opportunity through rigorous understanding of pathophysiology, clinical, regulatory, competitive and payor dynamics Identify and creating market development strategies and messaging to enable commercial and clinical field team to drive growth globally Support strategic accounts globally, focusing on nuanced understanding of scientific, technical, medical, competitive, and interpersonal dynamics to drive growth Source external opportunities from the perspective of in-licensing, co-development, commercialization, etc

Corindus is a startup business unit that joined Siemens as a strategic acquisition.Product manager for first of its kind Remote Surgical Robotics - expanding acces to interventional procedures through disruptive technologies. Reporting to global marketing head for Corindus.Promoted in ~ 6 months of joining

Partnered with 7 global regional teams, across 30+ countries to drive global $500M annual rev portfolio.-Managed Global Demand of $500M portfolio during one of the most dynamic market conditions (COVID-19)-Managed the global, commercial impact due to to one of the largest plant shutdowns in BD history - Served as marketing leader for sustaining engineering & cost to win projects across functions (manufacturing, R&D, quality), businesses, and regions - Led the process and proposed significant improvements to global market model excellence for 30+ countries

Designed and gained approval from leadership on custom position to reflect my background, experience, and future ambitions Labeled as an “intrapreneur,” leadership crafted this unique, hybrid role & title (“Front End Innovation Leader”)- Upstream strategic marketing leader driving targeted R&D innovation opportunities for $4B/annual business unit.-assessed the overall home care market business opportunity for new product and service concepts -proposed and secured funding for two new projects, hired full time consultant interns, and provided close guidance for assessments in adjacent markets -led concept development workshops with cross functional teams for unmet clinical needs-engaged multiple business units on an ongoing basis to identify customer needs that otherwise would not be prioritized due to the nature of their value proposition relative to individual business unit strategies-developed KOL partnerships for ethnographic research -developed co-creation partnerships with leading hospital institutions - Cleveland Clinic & Johns Hopkins

Focus: strategic planning, inorganic and organic growth assessments, mergers and acquisitions, IP licensing

Biotech startup out of Johns Hopkins University focusing on a treatment for type 2 diabetes based on insights from bariatric surgery's weight independent effect on type 2 diabetes. 😎

-Proposed and validated the initial therapeutic concept for a novel treatment for diabetes based on surgical insights. -Identified and recruited KOLs across different domains in order to provide critical feedback and add credibility to the idea. -In house product leader, coordinating commercial, scientific, technical, and competitive intelligence activities -Served as the Principal Investigator of a National Science Foundation Small Business Grant between Johns Hopkins & Glyscend - managed relevant P&L activities. -Designing and executed pre-clinical studies in animals (rats & pigs)-Presented to investors on Glyscend's overall mission and capital requirements.

• Uncovered ~50 unique, clustered problem statements (needs) in cardiac rhythm management based on 200+ hours of direct ethnography and interviews in India spanning 3 consecutive weeks in 3 states in public and private clinical care settings • Down selected to 1 innovation target and solution concept by partnering with Medtronic engineers to identify and prioritize key filtration criteria • Prioritized and proposed rural health kiosk model to target 70% of Indians based on iteration over 12 months and feedback from 40 rural medical practitioners (unlicensed clinicians)

Product development and quality assurance of decellularized biological meshes

Oncology detection and diagnosticsImage segmentation Image registration (alignment)Automated disease diagnosis

Electrospun nanofibers for soft tissue repair